A pair of papers published this month in JAMA Cardiology reveal some good news: doctors are getting better at treating pulmonary arterial hypertension, as evidenced by improved patient mortality rates and lowered hospitalization rates.

“In contrast to the original PAH experience, the contemporary approach to this disease is based on sound basic science and clinical trial data that is sizeable,” Dr Bradley A. Maron from Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts told Reuters Health by email. “Today PAH is treatable, and clinical care strives to achieve a high benchmark of success, including remediation of symptoms.”

Read more at www.medscape.com